Alerts will be sent to your verified email
Verify EmailLINCOLN
Lincoln Pharma
|
Anuh Pharma
|
Kwality Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Domestic Sales Growth - YoY
|
8.98 % | n/a | n/a |
R&D as a % of Total Sales
|
1.93 % | 0.0 | n/a |
Financials
|
|||
5 yr Average ROE
|
15.94 % | 14.73 % | 25.87 % |
5yr average Equity Multiplier
|
1.3 | 1.72 | 2.2 |
5yr Average Asset Turnover Ratio
|
0.84 | 1.28 | 1.09 |
5yr Avg Net Profit Margin
|
14.61 % | 6.73 % | 10.7 % |
Price to Book
|
1.68 | 3.24 | 3.99 |
P/E
|
13.74 | 22.3 | 26.42 |
5yr Avg Cash Conversion Cycle
|
24.49 Days | 32.26 Days | 46.51 Days |
Inventory Days
|
42.89 Days | 54.64 Days | 59.9 Days |
Days Receivable
|
90.22 Days | 101.36 Days | 110.56 Days |
Days Payable
|
111.35 Days | 121.84 Days | 112.27 Days |
5yr Average Interest Coverage Ratio
|
58.2 | 41.88 | 15.91 |
5yr Avg ROCE
|
20.48 % | 19.85 % | 34.24 % |
5yr Avg Operating Profit Margin
|
18.48 % | 9.86 % | 20.92 % |
5 yr average Debt to Equity
|
0.0 | 0.07 | 0.52 |
5yr CAGR Net Profit
|
12.65 % | 33.23 % | 23.39 % |
5yr Average Return on Assets
|
12.28 % | 8.83 % | 12.43 % |
Shareholdings
|
|||
Promoter Holding
|
49.78 % | 69.92 % | 54.83 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
7.73 % | -0.52 % | 0.4 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |